Esperion to Participate in Upcoming June Investor Conferences

Rhea-AI Summary

Esperion (NASDAQ: ESPR) announced its participation in upcoming June investor conferences. The company will present at the Jefferies Global Healthcare Conference in New York on June 5, 2024, at 4:30 p.m. ET, and the Goldman Sachs Healthcare Conference in Miami Beach on June 12, 2024, at 8:40 a.m. ET. Both events will be webcast live, with replays available on the Esperion website for 90 days. Esperion focuses on developing and commercializing innovative treatments for cardiovascular and cardiometabolic diseases, particularly targeting high cholesterol levels. The company aims to address the unmet health needs of millions of patients.

Positive

• Esperion's participation in prominent investor conferences may boost visibility and investor interest.
• Live webcasts and replays of the presentations increase accessibility for investors.
• Focus on innovative treatments for cardiovascular and cardiometabolic diseases addresses a significant health need.

Negative

• The press release lacks concrete financial or clinical data updates, which might be seen as a missed opportunity to provide more substantial information to investors.

ANN ARBOR, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of May, which can be found on our investor relations website.

Jefferies Global Healthcare Conference in New York on June 5, 2024, at 4:30 p.m. ET.

Goldman Sachs Healthcare Conference in Miami Beach on June 12, 2024, at 8:40 a.m. ET.

Live webcasts can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days.

Esperion Therapeutics
At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life’s work. For more information, visit esperion.com and esperionscience.com and follow us on X at twitter.com/EsperionInc.

Esperion Contact Information:
Investors:
investorrelations@esperion.com

Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438

FAQ

When is Esperion presenting at the Jefferies Global Healthcare Conference?

Esperion will present at the Jefferies Global Healthcare Conference in New York on June 5, 2024, at 4:30 p.m. ET.

When is Esperion presenting at the Goldman Sachs Healthcare Conference?

Esperion will present at the Goldman Sachs Healthcare Conference in Miami Beach on June 12, 2024, at 8:40 a.m. ET.

Where can I watch the live webcasts of Esperion's presentations?

The live webcasts can be accessed on the investor and media section of the Esperion website.

How long will the webcast replays be available on the Esperion website?

The webcast replays will be archived on the company's website for approximately 90 days.

What is the focus of Esperion's innovative medicines?

Esperion focuses on developing and commercializing innovative medicines to help improve outcomes for patients with cardiovascular and cardiometabolic diseases, particularly targeting high cholesterol levels.